Predicting response to multidrug regimens in cancer patients using cell line experiments and regularised regression models.
about
American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic CeAnti-Apoptotic Effects of Lentiviral Vector Transduction Promote Increased Rituximab Tolerance in Cancerous B-CellsRegularized logistic regression with network-based pairwise interaction for biomarker identification in breast cancer.hemaClass.org: Online One-By-One Microarray Normalization and Classification of Hematological Cancers for Precision MedicineMolecular classification of tissue from a transformed non-Hogkin's lymphoma case with unexpected long-time remission.Risk analysis of colorectal cancer incidence by gene expression analysis.Discovering novel pharmacogenomic biomarkers by imputing drug response in cancer patients from large genomics studies.Computational models for predicting drug responses in cancer research.A link prediction approach to cancer drug sensitivity prediction.Subtype assignment of CLL based on B-cell subset associated gene signatures from normal bone marrow - A proof of concept study.Consistency in large pharmacogenomic studies.A multiple myeloma classification system that associates normal B-cell subset phenotypes with prognosis
P2860
Q26782868-3549FF5A-A359-409B-A7FC-4323569508E9Q28551184-205A1F0E-8927-4FAA-84AE-6A7C201CEB7AQ35937992-6D63C8E5-919B-46DD-A6F1-09847BCC4D41Q36152713-614BE8DB-FCBD-4C01-AA9A-C3EFCE8C0B5AQ37579101-FB10A2F6-31B5-4EEF-A9C0-134893649E54Q37649691-373823EF-3A1C-4AE5-A166-00AEEDB9C4DCQ38605171-904EC603-1CFB-4B18-B127-02D2454CF260Q38904995-BC2D6876-0B30-4B3C-98F8-5229ED45F1B9Q42092953-58531AF7-B28C-4ACD-ADE3-2EE91A92688FQ50532164-4B9D8F68-31FE-4C1E-A84E-0C648D1A599EQ50541243-D4D3BC1D-03D3-486F-8C1B-CB2029E5323DQ58698408-D870616D-3E5B-4A59-A406-AEC0BA55FD34
P2860
Predicting response to multidrug regimens in cancer patients using cell line experiments and regularised regression models.
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Predicting response to multidr ...... regularised regression models.
@ast
Predicting response to multidr ...... regularised regression models.
@en
type
label
Predicting response to multidr ...... regularised regression models.
@ast
Predicting response to multidr ...... regularised regression models.
@en
prefLabel
Predicting response to multidr ...... regularised regression models.
@ast
Predicting response to multidr ...... regularised regression models.
@en
P2093
P2860
P50
P1433
P1476
Predicting response to multidr ...... regularised regression models.
@en
P2093
Alexander Schmitz
Ken H Young
Malene K Kjeldsen
Maria Bach Laursen
Steffen Falgreen
Zijun Y Xu-Monette
P2860
P2888
P356
10.1186/S12885-015-1237-6
P407
P50
P577
2015-04-08T00:00:00Z
P5875
P6179
1013234089